BUSINESS News 23andMe Lays Off 40% of Staff, Shuts Drug Development Business HS 11/11/2024 Advertisements The genetics company is closing a unit that was once seen as core to its future. Source link Continue Reading Previous Aristocrat to Sell Palarium Mobile Gaming for Up to $820 MillionNext Exxon Says Trump Should Keep U.S. in Paris Climate Pact More Stories BUSINESS News American Airlines Says Flights Resuming After Technical Issue HS 24/12/2024 BUSINESS News Auto & Transport Roundup: Market Talk HS 24/12/2024 BUSINESS News Financial Services Roundup: Market Talk HS 24/12/2024